Loading organizations...
§ Venture Capital · Beijing, China
No specific details or factual information about this organization are available in the provided research materials, precluding a description.
Fenghai Capital, operating in connection with FengHe Group, is an Asian investment management firm based in Singapore that manages hedge funds and venture capital investments across the broader Asian region. The firm focuses on identifying strategic opportunities within both public and private equity markets, generating financial returns for accredited and institutional investors through its specialized investment vehicles. Operating the flagship FengHe Asia Fund, the organization has maintained a consistent long/short equity strategy over the past 10 years to navigate complex regional market fluctuations. The firm's executive leadership team includes prominent financial industry figures and managing partners such as Chairman John Wu, Chief Investment Officer Matt Hu, and Chief Executive Officer Kwek Hyen Yong. Fenghai Capital was officially established as FengHe Fund Management Group in the year 2009 by founders Matt Hu and John Wu.
Fenghai Capital has 1 tracked investment across 1 company. The latest tracked deal is $31.0M Series B in China Immunotech in October 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 11, 2021 | China Immunotech | $31.0M Series B | China Growth Capital | Beijing Changping Science Park Development, Guangzhou Sanheyue, Sangel Capital, Start Point Advisors, Jianwei YUAN |